BACKGROUND: Risks and mechanisms of extension of conservatively managed spontaneous coronary artery dissection (SCAD) remain incompletely understood. Study objectives were to (1) evaluate mechanisms of early SCAD evolution through serial angiographic analysis, and (2) determine predictors of early SCAD progression.
S
pontaneous coronary artery dissection (SCAD) is an important, nonatherosclerotic cause of myocardial infarction and sudden death, especially in young individuals. 1, 2 Although the prevalence remains unknown, SCAD may be more common than previously thought and is disproportionately observed in women without traditional atherosclerotic risk factors. 3, 4 Associations between SCAD and several different conditions have been shown, including coronary tortuosity, pregnancy, and fibromuscular dysplasia. [5] [6] [7] SCAD leads to myocardial infarction through separation of the coronary arterial intima/media (dissection) causing luminal obstruction and accumulation of deeper intramural hematoma (IMH) resulting in compressive luminal stenosis. However, the inciting pathological event remains unclear. Two mechanistic hypotheses have been proposed. The first is that intimal dissection allows blood from the lumen to penetrate into the vessel wall, thereby creating a false lumen. This inside-out hypothesis is the predominantly proposed mechanism in other vascular beds, including cervical artery dissection. 8, 9 The second hypothesis is that formation of an IMH within the arterial media occurs as the primary process, leading to a secondary intimal tear in some patients (outside-in). [10] [11] [12] [13] In addition to uncertainties on SCAD initiation, the evolution of SCAD lesions in the early stages after presentation has not previously been studied. Serial angiography in patients presenting with SCAD provides an opportunity to obtain insight into initiating mechanisms as well as dynamics of early propagation of this increasingly recognized yet still poorly understood cause of acute coronary syndrome.
The optimal treatment of patients presenting with acute coronary syndrome because of SCAD remains unknown. Percutaneous coronary intervention (PCI) is associated with a higher risk of complications and lower technical success in this patient population. 1, 14 Observational studies have shown favorable long-term outcomes after conservative management. [15] [16] [17] Hence, a noninterventional approach is currently recommended in patients who are clinically stable. However, prior studies have also raised some concern for risk of early worsening of SCAD after initial conservative management, resulting in unanticipated adverse clinical events in the first few days after presentation. 14, 15 Because of small sample size in these studies, both the quantitative risk for SCAD extension and the duration of at-risk period remain incompletely understood. More so, clinical and angiographic features that might predispose to risk of extension have not previously been evaluated.
It should be recognized that until recently, the SCAD literature was limited to isolated case reports or very small case series. Much knowledge gain has occurred since 2011, in part through development of SCAD registries and through lessons learned from intravascular imaging studies. 10, 18, 19 Despite the resulting increase in SCAD awareness and recognition, most practitioners may still only encounter small numbers of patients in the acute setting and even then the diagnosis may not be immediately apparent. Thus, it seems highly unlikely that there will ever be a randomized trial of acute invasive versus conservative therapy. More so, systematic and routine repeat early angiography will likely never be undertaken, in part because of the increased risk of catheter-related trauma in SCAD. 20 Thus, the best available data from clinical studies in the acute and early stages will continue to be observational and subject to limitations of selection bias and retrospective analysis. Recognizing these limitations, there are still important clinical and pathological knowledge gaps that are now able to be addressed because of large sample sizes of SCAD obtained through registry accrual. In this regard, we performed a retrospective study of a large series of SCAD patients managed with initial conservative therapy. The goals of the study were (1) to evaluate the acute natural history of SCAD evolution and obtain insight into SCAD mechanisms through serial early angiographic analysis, and (2) evaluate the risk, timing, and angiographic predictors of clinically important SCAD progression after initial conservative management.
METHODS

Study Design
The study was approved by the Mayo Clinic Institutional Review Board, and subjects gave informed consent. This was a retrospective study from the Virtual Multicenter Mayo Clinic SCAD Registry, an ongoing retrospective and prospective multicenter international registry. The diagnosis of SCAD was
WHAT IS KNOWN
• Conservative management is currently recommended for spontaneous coronary artery dissection (SCAD) in the absence of major vessel occlusion.
• The risks of SCAD extension after conservative therapy are poorly understood.
WHAT THE STUDY ADDS
• This registry study of 240 conservatively managed patients with SCAD demonstrated 1 in 6 to experience clinically important early SCAD extension, most within 6 days of presentation.
• Isolated intramural hematoma (ie, absence of intimal dissection) confers a higher risk of SCAD extension and clinical deterioration.
• Intramural hematoma often precedes the development of intimal dissection, suggesting the pathological process of SCAD may begin in the media, with intimal disruption occurring as a secondary, decompressive process.
confirmed on review of coronary angiograms by at least 2 experienced interventional cardiologists with subsequent collection of patient medical records, narratives, and surveys. 1, 21 Atherosclerotic and iatrogenic dissections were excluded. Study outline is illustrated in Figure I in the Data Supplement. The data, analytic methods, and study materials will not be made available to other researchers for purposes of reproducing the results or replication the procedure.
SCAD Progression Versus Controls
Of 546 patients enrolled in the Mayo SCAD registry during the study period of January 2000 to February 2017, 240 patients with complete medical records were identified with confirmed SCAD who were managed conservatively after index angiography. From this, 42 patients were identified as having clinically important SCAD progression, defined as (1) clinical concern for new ischemia in addition to (2) 22 Follow-up data were derived from patient contact (eg, clinical appointments, medication refills), patient directed updates, periodic prospective nursing assessments, and follow-up surveys.
Angiographic Natural History
Of the entire conservatively managed cohort, 82 were identified to have undergone repeat angiography within 14 days of presentation. Patient baseline angiographic images, lesion characteristics, angiographic evolution, and revascularization strategies were reviewed. Coronary lesion severity was assessed visually using 2 orthogonal views. Coronary blood flow by angiography was scored using the TIMI system. 23 SCAD diagnosis and lesion morphology were confirmed by independent angiographic review (T.M.W., R.G.). IMH was diagnosed based on the presence of diffuse stenosis in the absence of atherosclerosis as described elsewhere. 1, 5, 13 The presence of intimal dissection or tear was diagnosed based on contrast staining in the vessel wall or appearance of multiple lumens. Angiographic improvement was defined as reduction in luminal stenosis, decrease in lesion length, and improvement in TIMI blood flow.
OCT Substudy
A selected subset of patients underwent intracoronary imaging by optical coherence tomography (OCT) for SCAD assessment. Images were reviewed and evaluated for presence of IMH and intimal dissection for inclusion in a subgroup analysis. Offline measurements of intimo-medial thickness were performed using frame by frame review of acquired OCT images with proprietary software, and 3-dimensional OCT reconstruction was performed on selected cases using OPTIS Flythrough technology (Abbott, Abbott Park, IL).
Statistical Analysis
Continuous variables are presented as mean±SD. Categorical variables are represented by frequencies or percentages of total patients or median and interquartile range if non-normal. Comparisons between groups were tested using Student t test for normal continuous data, rank-sum test for ordinal and non-normal data, and Pearson χ 2 testing for nominal data. Kaplan-Meier methods were used to estimate time-toevent distributions for the end points of myocardial infarction, recurrent SCAD, and target vessel revascularization. Logistic regression was used to test covariate associations with clinical and angiographic worsening. Random forest imputation was used to fill missing values of covariates. Statistical analyses were conducted using JMP version 10.0 and SAS version 9 (SAS Institute, Cary, NC). Hypothesis testing was 2 sided with 0.05 significance levels.
RESULTS
SCAD Progression Versus Controls
A total of 82 of 240 (34.2%) patients underwent early repeat angiography within 14 days of index SCAD presentation, of whom 42 (17.5% of entire conservatively managed SCAD cohort) demonstrated clinically significant early SCAD progression (clinical concern for new ischemia in addition to new critical coronary obstruction on repeat angiography). Tables 1 and 2 illustrate clinical and angiographic features compared with the control group of those who remained clinically stable. Those with significant SCAD progression did not exhibit a statistically significant difference in age (mean age, 46.1±9.1 versus 48.3±9.4 years; P=0.16) but had more frequently presented with higher risk features, such as ST-segment-elevation myocardial infarction and multivessel SCAD. This group also had greater prevalence of vascular fibromuscular dysplasia (54.8% versus 32.3%; P=0.02). Both groups were predominantly female with low prevalence of atherosclerotic risk factors. The left anterior descending coronary artery was the most commonly involved vessel (61.9% versus 55.1%; P=0.42). Of those undergoing repeat angiography with clinical SCAD progression, all had recurrence of chest discomfort, 19.0% had new ischemic ECG changes, 16.7% had a new increase in cardiac biomarkers, and 2.4% had ventricular arrhythmia. There were no statistically significant differences in risk of SCAD extension for the group within the past 5 years of study (31 of 187; 17%) versus older era (11 of 53; 21%; P=0.50). Timing of SCAD extension did not differ between eras (both groups exhibited highest risk on day 1; median, 3 days). Figure 1 illustrates timing of SCAD progression event diagnosis after index presentation. This indicates that occlusion or new ischemia because of dynamic SCAD lesion changes is highest in the early time period after presentation. Most occurred on day 1, with 79% having occurred by day 4. Only 4.8% of clinically important SCAD progression events (representing 1% of the entire conservatively managed cohort) occurred beyond 6 days.
Angiographic Features Associated With SCAD Progression
A total of 40 patients in the control group underwent repeat angiography but did not fulfill the angiographic criteria for SCAD progression. The indication for angiography in these patients was chest pain. Of these, 65% demonstrated either no change or improvement in initial SCAD lesion characteristics (mean, 4.5±2.8 days), and 35% demonstrated lesion progression but without fulfilling criteria for critical coronary obstruction. Values are n (%) or mean±SD or median (interquartile range) unless otherwise indicated. EF indicates ejection fraction; NSTEMI, non-ST-segment-elevation myocardial infarction; SCAD, spontaneous coronary artery dissection; and STEMI, ST-segment-elevation myocardial infarction. *n=178, †n=39, ‡n=170.
Early Natural History of SCAD by Angiographic Analysis
We compared all repeat angiograms (n=82) with their baseline studies to obtain insight into the early natural history of SCAD, acknowledging that repeat angiography was performed selectively and not routinely. Dynamic changes of those demonstrating isolated IMH at baseline with the group exhibiting initial visible intimal dissection were compared ( Figure 3A and 3B. Assessment of intimomedial thickness longitudinally in the SCAD lesions is illustrated in Figure 3C . Intimo-medial thickness was lowest near the midpoint of the isolated IMH lesion (n=15 cases; mean, 258±70 µm) or at the level of disruption in the 2 cases with intimal tear present (mean, 155±7 µm).
Revascularization After Initial Conservative Management
Of the patients who exhibited clinically important SCAD progression, 24 of 42 (57.1%) underwent emergent revascularization after failed initial conservative therapy (20 PCI, 8 coronary artery bypass graft, including 4 with failed PCI), the remainder being managed with continued conservative therapy. Of the 40 patients who underwent repeat angiography but did not fulfill criteria for new critical obstruction, 17 did undergo revascularization at the time of repeat study, all by PCI, of which 2 were unsuccessful. Thus, from the entire cohort, 41 patients (17.1%) underwent emergency revascularization after attempted initial conservative therapy. Figure 4 demonstrates that the presence of isolated IMH at baseline angiography or multivessel SCAD involvement was predictive of clinically important, angiographically evident early SCAD progression. Baseline luminal stenosis >80% was also predictive of progression.
Multivariate Predictors of SCAD Progression
Long-Term Outcomes
Kaplan-Meier analyses in Figure 5 
DISCUSSION
In this large retrospective study of conservatively managed SCAD, the principal findings were as follows: (1) conservative management is associated with a 1 in 6 
Clinical Implications
Conservative therapy has been considered the preferred strategy for management of acute SCAD in the absence of large-vessel occlusion. [15] [16] [17] [18] [19] Such a noninterventional approach has been advocated primarily because of the elevated risk of acute complications from percutaneous intervention in this setting. 1, 15, 24 The current study, by demonstrating an early serious hazard for worsening ischemia after a noninvasive initial approach often leading to subsequent emergency revascularization, challenges the perceived safety of conservative management. Initial concerns for early SCAD progression had been raised by a prior smaller study which retrospectively compared conservative management with PCI.
14 By virtue of a much larger sample size derived from a prospective SCAD registry, the current study not only suggests the hazard is greater than previously considered, underscoring challenges of acute SCAD management, but has also enabled detailed characterization of timing and risk.
Thus, the optimal initial therapy for SCAD remains uncertain. Coronary artery bypass grafting, while being associated with good in-hospital outcomes in selected patients, is plagued by subsequent issues with long-term graft patency after native vessel healing and does not protect against recurrent dissection. 14 However, particularly given the demonstration that isolated IMH confers greater risk of serious early progression, it could be argued that an upfront percutaneous approach, such as fenestration (percutaneous transluminal coronary angioplasty or cutting balloon) to decompress the hematoma, might be a reasonable strategy in selected cases without baseline intimal dissection. 19, 25, 26 Collaborative accumulation of experience with such approaches, together with collection of longer term follow-up data, will be helpful to determine whether interventional therapies can be reconsidered as first line in selected patients with SCAD. The study findings do not refute a primary conservative approach but underscore that such an approach cannot be undertaken with high degrees of confidence in stabilization and uneventful acute outcome. At the very least, a risk-directed, carefully considered period of inpatient hospitalization should be the mainstay of conservative therapy. The findings that the risk for acute deterioration was highest very early after initial presentation and diminished rapidly after day 6 underscore the dynamic nature of acute SCAD early after presentation while also providing corresponding reassurance for stability beyond this period for those patients who did not experience deterioration. 
Risk of Early SCAD Progression
Only about half of the patients who underwent repeat angiography demonstrated clinically important SCAD progression. This most likely illustrates challenges encountered in ongoing clinical evaluation, as well as selection biases that may influence the decision to perform repeat study. To address this, we chose strict criteria to define clinically important SCAD progression-namely clinical concern for new ischemia together with proof of new critical coronary obstruction and worsening of SCAD vessel flow. This enabled accurate characterization of the SCAD population truly at risk for deterioration as well as evaluation of timing of the at-risk period.
A key observation was that the early course of conservatively managed SCAD differed according to morphology of the index lesion at angiography. Patients with isolated IMH and the absence of angiographic intimal disruption carried a higher risk of deterioration. This might suggest that the presence of an intimal tear could be a protective feature in some patients with SCAD, possibly via decompression of IMH into the lumen.
The observation that some patients undergoing repeat angiography did not have evidence of worsening coronary obstruction suggests potential nonischemic mechanisms for recurrent chest pain or lack of initial SCAD recognition by managing providers. In this regard, dissections of the aorta, cervical and mesenteric vessels frequently present with pain in the absence of an ischemic mechanism. Potential causes of pain with SCAD might include neurosensory effect of the dissection itself (including, eg, IMH and adventitial stretch), secondary vasospasm, and dysfunctional/dissected microvasculature. It is crucial for clinicians to appreciate that ongoing pain may not have an ischemic substrate, not only given the high risk of complications from PCI in this setting but also because of the potential for pain to continue even with successful revascularization. Thus, it remains important to carefully consider which patients may benefit from repeat angiographic study and to avoid routine early repeat angiography after initial SCAD presentation.
Predictors of Early SCAD Progression
Prior angiographic classifications have been useful in aiding pattern recognition of SCAD at angiography and have contributed to the increased recognition of this disease as an important cause of acute coronary syndrome. 13, 18, 27 However, these classifications have not been shown to impact clinical outcomes. The current study expands this concept by demonstrating that straightforward assessment for presence or absence of intimal dissection can stratify patients at risk for early SCAD angiographic extension longitudinally and axially in the vessel in addition to early clinical deterioration after conservative management. Markers of SCAD burden, including multivessel involvement, and degree of luminal stenosis at baseline were also shown to be predictive of angiographic and clinical worsening.
Angiographic Natural History of SCAD
It has previously been hypothesized that luminal obstruction in SCAD may initiate from intimal disruption, with the entry tear facilitating false lumen creation and hematoma accumulation deeper in the vessel wall. Alternatively, IMH alone, perhaps from vasa vasora proliferation and rupture, has been proposed as the inciting pathological event resulting in luminal compression, ischemia, and even subsequent intimal disruption. 24, 28, 29 The current study provides 3 findings that support the pathological hypothesis of IMH formation as the primary process in many cases of SCAD. First, the observation that several cases of apparent isolated IMH at index angiography demonstrated subsequent progression to intimal tear on repeat imaging. This was frequently associated with improved distal vessel flow and reduced luminal obstruction, consistent with a decompressive process. Second, IMH was shown to progress both proximally and downstream to the initial lesion. This would argue against an entry tear and distal propagating hypothesis, such as that seen with aortic dissection as a result of forward shear forces. Indeed, patients with IMH alone demonstrated significantly more proximal lesion progression than those with intimal tear. Third, the findings from intracoronary imaging in a selected subset support a primary IMH process. 10, 30, 31 In this regard, Alfonso et al 10 previously reported the use of OCT in SCAD evaluation and described variation in intimo-medial thickness along the length of SCAD lesions. This study also detected intimal dissection in 7 of the 11 cases, 4 of which had been undetectable by angiography. The current study corroborates progressive wall thinning and also demonstrated the thinnest point to be at the edge of the dissection. Despite careful analysis, intimal dissection was not seen in 15 of the 17 cases. Differences in selection criteria and small sample sizes in both studies might explain the difference between studies. Although The covariates included were isolated intramural hematoma (IMH; vs tear), multivessel disease, lesion length (mm), luminal stenosis, and left anterior descending (LAD) involvement (vs all other vessels). CL indicates confidence limit. collectively these observations support an outside-in hypothesis in the majority, an inside-out process cannot be completely excluded. It is possible that angiography and OCT lacked the sensitivity for detection of small dissections. In addition, rapid sealing of a primary intimal tear may have occurred before angiography in some although the thickness of the intimo-medial lining at the lesion origin would argue against this occurring as an entry phenomenon, if at all.
Only a highly selected subset in the current study underwent OCT, based on availability of the technology, perceived safety of performing the procedure and likely in cases of angiographic ambiguity (eg, isolated IMH, no visible tear). The lack of systematic OCT utilization means that quantitative conclusions must be tempered. Although there were no complications in this selected subgroup, we advocate that this imaging technique be considered only in cases of angiographic uncertainty and to be preferably avoided where there is a visible intimal dissection plane because of the risk of hydraulic propagation. These serial imaging-based natural history findings have implications for further research into SCAD pathogenesis and mechanisms, supporting focus at the level of the arterial media and adventitia. The observations also have implications for selection of invasive therapies with proximal entry stenting seemingly being a less logical option than, for example, a decompressive balloon angioplasty approach. 19 Clearly, these are speculative suggestions that may merit further study. Future pathological studies will offer more information on vascular wall processes in SCAD. The current study provides complementary insight that cannot be obtained with static pathological analysis alone, by virtue of tracking dynamic changes through repeated coronary imaging in the early stages of disease.
Recognizing the proposed principal hypothesis above, a primary intimal process may well be the culprit in some. Certainly, cases in the current study were encountered where there was clear intimal separation by angiography, without associated luminal compression from overt hematoma. Moreover, the increased susceptibility of nonaffected coronary regions to iatrogenic dissection also supports some structural weakness on the luminal aspect of the arterial wall that may predispose to intimal separation. 18, 20 This raises the possibility of there being distinct types of SCAD. Whether this is relevant in terms of clinical outcome may warrant further study.
Study Limitations
Although this study enabled the evaluation of early SCAD natural history by repeat high-resolution imaging, a limitation is that relook angiography was selective and not systematic. More so, angiography was performed at variable time points after presentation. Thus, it is not possible to extrapolate the dynamic findings to all-comers presenting with SCAD. Computed tomographic angiography could be an alternate method for routine re-study although this modality has reduced sensitivity compared with invasive angiography and can miss SCAD. [31] [32] [33] Additional limitations of this study include its retrospective design and associated biases, as well as survivor and referral biases associated with use of a registry. Although we think it unlikely that there was a meaningful degree of lesion progression in those who did not undergo repeat angiography, the possibility of silent extension of disease cannot be excluded. The inherent variability in SCAD recognition and choice of initial management strategies by treating providers are further limitations that cannot be addressed by this study design. It is also possible that under-recognition of SCAD in earlier years and changes in selection of treatment over time may have influenced study findings.
Conclusions
This retrospective registry study demonstrated that SCAD is a highly dynamic process and carries an important hazard for early serious clinical deterioration when managed conservatively. The risk is higher in those with isolated IMH at baseline. The high-risk period for clinical instability in medically managed SCAD appears to be within 6 days of presentation. The observations from this study suggest that IMH precedes intimal disruption, consistent with an outside-in pathological mechanism originating in the vessel media.
